CNBX PHARMACEUTICALS INC. (CNBX) Operating cash flow 2016–2025
CNBX PHARMACEUTICALS INC. (CNBX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$171,305FY2025 · since FY2016: -$120,103 → -$171,305
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$171,305 | +29.9% |
| FY2024 | -$244,269 | -117.1% |
| FY2023 | -$112,521 | +93.3% |
| FY2022 | -$1.7M | +32.6% |
| FY2021 | -$2.5M | +10.2% |
| FY2020 | -$2.8M | +10.3% |
| FY2019 | -$3.1M | -56.7% |
| FY2018 | -$2.0M | -128.7% |
| FY2017 | -$863,567 | -619.0% |
| FY2016 | -$120,103 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CNBX financial trends
CNBX RevenueCNBX Net incomeCNBX Net marginCNBX Gross profitCNBX Gross marginCNBX Operating incomeCNBX Operating marginCNBX Free cash flowCNBX Capital expendituresCNBX Return on equityCNBX Stock buybacksCNBX Dividends paidCNBX Total assetsCNBX Total liabilitiesCNBX Shareholders’ equityCNBX overview →